Meeting
2019 ASCO Annual Meeting
Image-guided surgery for tumor agnostic detection of solid tumors using the pH-activated micellar imaging agent ONM-100.
Authors
Floris Jan Voskuil
UMCG, Groningen, Netherlands
Floris Jan Voskuil , Pieter Jan Steinkamp , Marjory Koller , Bert van der Vegt , Jan Johannes Doff , Tian Zhao , Jeffrey P. Hartung , Yalia Jayalakshmi , Baran D. Sumer , Jinming Gao , Max J.H. Witjes , Gooitzen Michell Van Dam
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics and Tumor Biology (Nonimmuno)
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Molecular Diagnostics and Imaging
Clinical Trial Registration Number
NTR 7085
Citation
J Clin Oncol 37, 2019 (suppl; abstr 3068)
DOI
10.1200/JCO.2019.37.15_suppl.3068
Abstract #
3068
Poster Bd #
60
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
A phase I study of the safety and activation of a cathepsin-activatable fluorescent cancer-specific probe LUM015.
First Author: Melodi Javid Whitley
First Author: Thomas A. Hope
Poster
2022 ASCO Annual Meeting
A phase 1 trial of the bifunctional EGFR/TGFβ fusion protein BCA101 alone and in combination with pembrolizumab in patients with advanced solid tumors.
First Author: Philippe L. Bedard
Poster
2022 ASCO Annual Meeting
A multicenter, open-label, phase 1a/b study of HC-7366, a modulator of integrated stress response (ISR) kinase GCN2 in subjects with advanced solid tumors.
First Author: Meredith Pelster